Top

Published in:

01-05-2013 | Editorial

To cool or not to cool non-shockable cardiac arrest patients: it is time for randomized controlled trials

Authors: Nicolas Deye, Jasmin Arrich, Alain Cariou

Published in: Intensive Care Medicine | Issue 5/2013

Excerpt

Based on remarkable effects mostly observed in shockable patients, therapeutic hypothermia (TH) has been widely proposed for comatose patients after cardiac arrest (CA) [1]. Although used in patients who have been resuscitated from a non-shockable out-of-hospital CA (OHCA), there are no large randomized controlled trials (RCTs) evaluating the clinical impact of TH in this situation. As a result, the use of TH in OHCA patients with a non-shockable rhythm is still controversial, as reflected by the discrepancy between practice, recommendations and expert opinion [1, 2]. …

Morrison LJ, Deakin CD, Morley PT, Callaway CW, Kerber RE, Kronick SL, Lavonas EJ, Link MS, Neumar RW, Otto CW, Parr M, Shuster M, Sunde K, Peberdy MA, Tang W, Vanden Hoek TL, Böttiger BW, Drajer S, Lim HS, Nolan JP, Advanced Life Support Chapter Collaborators (2010) Part 8: Advanced Life Support: 2010 international consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment recommendations. Circulation 122:S345–S421PubMedCrossRef

Nunnally ME, Jaeschke R, Bellingan GJ, Lacroix J, Mourvillier B, Rodriguez-Vega GM, Rubertsson S, Vassilakopoulos T, Weinert C, Zanotti-Cavazzoni S, Buchman TG (2011) Targeted temperature management in critical care: a report and recommendations from five professional societies. Crit Care Med 39:1113–1125PubMedCrossRef

Vaahersalo J, Hiltunen P, Tiainen M, Oksanen T, Kaukonen KM, Kurola J, Ruokonen E, Tenhunen J, Ala-Kokko T, Lund V, Reinikainen M, Kiviniemi O, Silfvast T, Kuisma M, Varpula T, Pettila V; the FINNRESUSCI Study Group (2013) Therapeutic hypothermia after out-of-hospital cardiac arrest in Finnish intensive care units: the FINNRESUSCI study. Intensive Care Med. doi:10.1007/s00134-013-2868-1

Testori C, Sterz F, Holzer M, Losert H, Arrich J, Herkner H, Krizanac D, Wallmüller C, Stratil P, Schober A, Hörburger D, Stöckl M, Weiser C, Uray T (2012) The beneficial effect of mild therapeutic hypothermia depends on the time of complete circulatory standstill in patients with cardiac arrest. Resuscitation 83:596–601PubMedCrossRef

Che D, Li L, Kopil CM, Liu Z, Guo W, Neumar RW (2011) Impact of therapeutic hypothermia onset and duration on survival, neurologic function, and neurodegeneration after cardiac arrest. Crit Care Med 39:1423–1430PubMedCrossRef

Tagin MA, Woolcott CG, Vincer MJ, Whyte RK, Stinson DA (2012) Hypothermia for neonatal hypoxic ischemic encephalopathy: an updated systematic review and meta-analysis. Arch Pediatr Adolesc Med 166:558–566PubMedCrossRef

Nielsen N, Hovdenes J, Nilsson F, Rubertsson S, Stammet P, Sunde K, Valsson F, Wanscher M, Friberg H, for the Hypothermia Network (2009) Outcome, timing and adverse events in therapeutic hypothermia after out-of-hospital cardiac arrest. Acta Anaesthesiol Scand 53:926–934PubMedCrossRef

Kim YM, Yimb YW, Jeong SH, Klem ML, Callaway CW (2012) Does therapeutic hypothermia benefit adult cardiac arrest patients presenting with non-shockable initial rhythms?: a systematic review and meta-analysis of randomized and non-randomized studies. Resuscitation 83:188–196PubMedCrossRef

Testori C, Sterz F, Behringer W, Haugk M, Uray T, Zeiner A, Janata A, Arrich J, Holzer M, Losert H (2011) Mild therapeutic hypothermia is associated with favourable outcome in patients after cardiac arrest with non-shockable rhythms. Resuscitation 82:1162–1167PubMedCrossRef

10.

Dumas F, Grimaldi D, Zuber B, Fichet J, Charpentier J, Pène F, Vivien B, Varenne O, Carli P, Jouven X, Empana JP, Cariou C (2011) Is hypothermia after cardiac arrest effective in both shockable and nonshockable patients?: insights from a large registry. Circulation 123:877–886PubMedCrossRef

11.

Storm C, Nee J, Roser M, Jörres A, Hasper D (2012) Mild hypothermia treatment in patients resuscitated from non-shockable cardiac arrest. Emerg Med J 29:100–103PubMedCrossRef

12.

Lundbye JB, Rai M, Ramu B, Hosseini-Khalili A, Li D, Slim HB, Bhavnani SP, Nair SU, Kluger J (2012) Therapeutic hypothermia is associated with improved neurologic outcome and survival in cardiac arrest survivors of non-shockable rhythms. Resuscitation 83:202–207PubMedCrossRef

13.

Arrich J, Holzer M, Havel C, Müllner M, Herkner H (2012) Hypothermia for neuroprotection in adults after cardiopulmonary resuscitation. Cochrane Database Syst Rev 9:CD004128PubMed

14.

Xiao G, Guo Q, Shu M, Xie X, Deng J, Zhu Y, Wan C (2013) Safety profile and outcome of mild therapeutic hypothermia in patients following cardiac arrest: systematic review and meta-analysis. Emerg Med J 30:91–100PubMedCrossRef

15.

Perbet S, Mongardon N, Dumas F, Bruel C, Lemiale V, Mourvillier B, Carli P, Varenne O, Mira JP, Wolff M, Cariou A (2011) Early onset pneumonia after cardiac arrest: characteristics, risk factors and influence on prognosis. Am J Respir Crit Care Med 184:1048–1054PubMedCrossRef

Title: To cool or not to cool non-shockable cardiac arrest patients: it is time for randomized controlled trials
Authors: Nicolas Deye
Jasmin Arrich
Alain Cariou
Publication date: 01-05-2013
Publisher: Springer-Verlag
Published in: Intensive Care Medicine / Issue 5/2013
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI: https://doi.org/10.1007/s00134-013-2877-0

Keynote webinar | Spotlight on medication adherence

Springer Medicine

To cool or not to cool non-shockable cardiac arrest patients: it is time for randomized controlled trials

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 5/2013

Optimized safety and function of the bicaval dual-lumen cannula by refined positioning and bedside management

Multimodality cardiac imaging for diagnosing rare causes of cardiac arrest

Ultrasound in critically ill patients: focus on diaphragm

Lower tidal volume strategy (≈3 ml/kg) combined with extracorporeal CO2 removal versus ‘conventional’ protective ventilation (6 ml/kg) in severe ARDS

Long-term outcomes and quality of life in critically ill patients with hematological or solid malignancies: a single center study

Randomised trials of 6 % tetrastarch (hydroxyethyl starch 130/0.4 or 0.42) for severe sepsis reporting mortality: systematic review and meta-analysis